Co-Partners
Associate Partners
Get App

Co-Partners

Associate Partners

Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 20, 10:15
2621.20
-126.9 (-4.62%)
VOLUME 20,545
LIVE
NSE
May 20, 10:16
2621.55
-123.45 (-4.5%)
VOLUME 620,575
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Profit & Loss account of Dr Reddys Laboratories

------------------- in Rs. Cr. -------------------
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 10,466.70 9,302.60 9,628.10 10,234.80 10,010.40
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 84.20 82.90
Revenue From Operations [Net] 10,466.70 9,302.60 9,628.10 10,150.60 9,927.50
Other Operating Revenues 158.80 56.70 91.70 57.10 83.50
Total Operating Revenues 10,625.50 9,359.30 9,719.80 10,207.70 10,011.00
Other Income 238.40 204.00 591.20 244.80 222.80
Total Revenue 10,863.90 9,563.30 10,311.00 10,452.50 10,233.80
EXPENSES
Cost Of Materials Consumed 2,103.20 2,011.00 1,904.60 1,988.50 2,248.40
Purchase Of Stock-In Trade 868.60 671.60 671.50 610.40 526.10
Operating And Direct Expenses 0.00 0.00 0.00 94.20 92.40
Changes In Inventories Of FG,WIP And Stock-In Trade 66.00 -51.60 1.90 -28.80 -28.90
Employee Benefit Expenses 1,931.90 1,843.00 1,803.30 1,710.00 1,490.90
Finance Costs 56.80 62.80 57.20 63.80 63.80
Depreciation And Amortisation Expenses 780.60 774.10 735.10 649.10 490.20
Other Expenses 3,356.10 3,555.40 3,592.90 3,429.40 3,291.00
Total Expenses 9,163.20 8,866.30 8,766.50 8,516.60 8,173.90
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,700.70 697.00 1,544.50 1,935.90 2,059.90
Exceptional Items 0.00 0.00 0.00 -355.90 0.00
Profit/Loss Before Tax 1,700.70 697.00 1,544.50 1,580.00 2,059.90
Tax Expenses-Continued Operations
Current Tax 423.40 138.10 182.60 416.00 376.70
Less: MAT Credit Entitlement 0.00 0.00 0.00 97.00 0.00
Deferred Tax 0.00 -8.00 -22.20 -93.50 3.80
Total Tax Expenses 423.40 130.10 160.40 225.50 380.50
Profit/Loss After Tax And Before ExtraOrdinary Items 1,277.30 566.90 1,384.10 1,354.50 1,679.40
Profit/Loss From Continuing Operations 1,277.30 566.90 1,384.10 1,354.50 1,679.40
Profit/Loss For The Period 1,277.30 566.90 1,384.10 1,354.50 1,679.40
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 76.98 34.19 83.05 79.42 99.00
Diluted EPS (Rs.) 76.85 34.12 82.88 79.14 98.00
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
Imported Raw Materials 0.00 0.00 0.00 766.80 867.70
Indigenous Raw Materials 0.00 0.00 0.00 1,221.70 1,380.70
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares 0.00 0.00 0.00 107.00 81.10
Indigenous Stores And Spares 0.00 0.00 0.00 322.10 294.40
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 0.00 399.20 335.30 340.50 340.80
Tax On Dividend 0.00 0.00 0.00 69.30 69.40
Equity Dividend Rate (%) 0.00 400.00 400.00 400.00 400.00
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for drreddyslaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.